Items Tagged ‘HCL’

October 7th, 2015

Zelboraf® Appears Active in Hairy Cell Leukemia That Has Progressed After Other Treatment


The medication Zelboraf® (vemurafenib) appears active in the treatment of hairy cell leukemia (HCL) that had progressed after previous therapy. These findings were published in New England Journal of Medicine. Hairy cell leukemia is a rare type of leukemia, or cancer of the immune cells. In HCL, the bone marrow makes too many lymphocytes (a […]

View full entry

Tags: BRAF, Hairy Cell Leukemia, HCL, Leukemia, News, vemurafenib, zelboraf